Catalyst Wire Dossier Catalyst Wire Dossier

Sublingual L-GSH

glutathione, reduced (L-form)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sublingual L-GSH, covering 2014-05-08 to 2014-05-08. Get the full timeline:

Most recent: Clinical Trial Update: Sublingual L-GSH Supplementation in Male Subjects With Smoking Habit and/or Hypertension [Phase 3]

See pricing